Form 13-F position report

GILEAD SCIENCES INC

Reported by GSA CAPITAL PARTNERS LLP

GILD CUSIP 375558103 Manager CIK 0001362033

Reported 30,194 shares, up 20,317 (205.7%) from the prior quarter.

Reported value 260.6%; share count 205.7% vs. the prior quarter.

Added
% of reported 13F value 0.27% This manager · Q3 2026
Shares 30,194 Quarter-end amount reported
Reported value $4,500,000 Fair value at quarter end
Consecutive quarters held 5 Through Q3 2026

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2021-12-31 0
2022-03-31 444000
2022-06-30 0
2023-03-31 226000
2023-06-30 0
2023-09-30 270000
2023-12-31 0
2024-03-31 462000
2024-06-30 0
2025-09-30 337000
2025-12-31 230000
2026-03-31 798000
2026-06-30 1248000
2026-09-30 4500000

Quarterly position history

How this manager's reported quarter-end position changed over time.

14 quarters
Quarterly reported position history for GILEAD SCIENCES INC held by GSA CAPITAL PARTNERS LLP.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q3 2026 Added 30,194 +20,317 (205.7%) 0.27% $4,500,000 2026-11-16
Q2 2026 Added 9,877 +4,151 (72.5%) 0.08% $1,248,000 2026-08-06
Q1 2026 Added 5,726 +3,851 (205.4%) 0.05% $798,000 2026-05-08
Q4 2025 Reduced 1,875 -1,160 (-38.2%) 0.02% $230,000 2026-02-06
Q3 2025 New 3,035 +3,035 (0.0%) 0.03% $337,000 2025-11-07
Q2 2024 Reduced 0 -6,302 (-100.0%) 0 $0 2024-08-15
Q1 2024 New 6,302 +6,302 (0.0%) 0.04% $462,000 2024-05-03
Q4 2023 Reduced 0 -3,603 (-100.0%) 0 $0 2024-02-16
Q3 2023 New 3,603 +3,603 (0.0%) 0.02% $270,000 2023-11-15
Q2 2023 Reduced 0 -2,719 (-100.0%) 0 $0 2023-08-14
Q1 2023 New 2,719 +2,719 (0.0%) 0.02% $226,000 2023-05-12
Q2 2022 Reduced 0 -7,468 (-100.0%) 0 $0 2022-08-09
Q1 2022 New 7,468 +7,468 (0.0%) 0.06% $444,000 2022-05-11
Q4 2021 Reduced 0 -3,442 (-100.0%) 0 $0 2022-02-14
Five years are shown. A free account unlocks the complete reported history. Unlock full history

Who else reported the position

2482 managers reported GILEAD SCIENCES INC for Q3 2026.

Managers reporting GILEAD SCIENCES INC in Q3 2026.
Manager Activity Shares Change % of reported 13F Reported value Tenure
BlackRock Inc Added 125,246,865 +3,402,757 0.27% $18,668,045,217 9 qtrs
VANGUARD CAPITAL MANAGEMENT LLC Added 81,175,627 +83,893 0.25% $12,099,227,204 3 qtrs
STATE STREET CORPORATION Reduced 60,954,967 -261,585 0.26% $9,085,337,831 54 qtrs
FMR LLC Reduced 58,265,696 -8,605,120 0.37% $8,684,501,953 54 qtrs
Invesco Ltd Reduced 38,662,436 -1,156,715 0.45% $5,762,636,028 54 qtrs
Capital World Investors Reduced 35,929,833 -5,059,142 0.65% $5,355,872,692 54 qtrs
VANGUARD PORTFOLIO MANAGEMENT LLC Added 35,685,818 +369,650 0.24% $5,318,971,173 3 qtrs
GEODE CAPITAL MANAGEMENT LLC Added 30,190,640 +124,998 0.23% $4,485,711,723 54 qtrs
PRICE T ROWE ASSOCIATES INC MD Reduced 27,664,121 -2,332,573 0.41% $4,123,338,000 54 qtrs
Capital Research Global Investors Added 23,980,766 +4,587,470 0.51% $3,574,341,919 54 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
September 30, 2026
Filed
November 16, 2026
Filing type
13F-HR
Position type
COM

Voting authority reported

Sole
30,194
Shared
0
None
0

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.